Fox-news/health/nutrition-and-fitness/weight-loss

• More Americans may be classified as obese under new definition, study suggests - New obesity criteria that add waist and body fat measures to BMI could classify nearly 70% of U.S. adults as obese, according to a new study.
• Fast food goes GLP-1: Shake Shack joins protein craze with new Ozempic-friendly menu - Fast food chains reshape menus for weight-loss drug era as Shake Shack launches high-protein 'Good Fit Menu' with lettuce wraps and lighter options
• Denise Austin, 68, still fits into her iconic ’80s leotards and reveals her daily fitness habit - Legendary fitness instructor Denise Austin, 68, still fits into her leotards from the '80s and '90s. The longtime TV host shares her secrets for lasting weight loss.
• Most talked-about diet trends of 2025 — and how they reshaped Americans' eating habits - The most popular diet trends of 2025 included the Mediterranean diet, keto, high-protein eating and the carnivore diet. Experts shared guidance on the risks and benefits of each approach.
• Jelly Roll’s 300-pound milestone tops a list of stunning celebrity weight-loss transformations - Hollywood stars revealed dramatic weight loss transformations in 2025, with Jelly Roll losing 300 pounds and Meghan Trainor showing her new figure.
• Obesity expert reveals the best way to decide if GLP-1s are right for you - Expert Dr. Salas-Whalen reveals that body composition testing, not just the number on your scale, is key to knowing whether GLP-1 weight-loss medications are right for you.
• New Ozempic-alternative diabetes pill burns fat without muscle loss, study suggests - Researchers have created an oral medication that could work alone or with GLP-1 drugs to improve metabolic health while preserving muscle mass in diabetes patients.
• Amy Schumer dropped 50 pounds to battle disease that 'can kill you' if untreated - Comedian Amy Schumer opens up about her health journey, Cushing syndrome recovery, and using Mounjaro medication after losing 50 pounds for her wellbeing.
• GLP-1 drugs may reach fewer than one in 10 people who need them, experts predict - The WHO issues its first official guidance on GLP-1 drugs for obesity treatment, as the disease affects over one billion people globally and is expected to double by 2030.
• Men with 'beer bellies' may face serious heart damage regardless of weight - New study reveals "beer bellies" increase heart damage risk even in people with normal weight, challenging traditional views on cardiovascular health.